Selection of patients for proton therapy to reduce risk of second primary lung and breast cancer.

Saved in:
Bibliographic Details
Title: Selection of patients for proton therapy to reduce risk of second primary lung and breast cancer.
Authors: Boersma LJ; Dept. Radiation Oncology (Maastro), GROW Research Institute for Oncology, Maastricht University Medical Centre+, Maastricht, the Netherlands. Electronic address: liesbeth.boersma@maastro.nl., Hessels A; Dept. Radiation Oncology, University Medical Center Groningen, University of Groningen, the Netherlands., Roberti S; Dept. Epidemiology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Seravalli E; Dept. Radiation Oncology, University Medical Centre Utrecht, Utrecht, the Netherlands., Bijker N; Dept. Radiotherapy, Amsterdam University Medical Centre, Amsterdam, the Netherlands., Coppes RP; Dept. Radiation Oncology, University Medical Center Groningen, University of Groningen, the Netherlands; Dept. Biomedical Sciences, University Medical Center Groningen, University of Groningen, the Netherlands., Crijns APG; Dept. Radiation Oncology, University Medical Center Groningen, University of Groningen, the Netherlands., Daniels L; Dept. Radiotherapy, Amsterdam University Medical Centre, Amsterdam, the Netherlands., Eekers DBP; Dept. Radiation Oncology (Maastro), GROW Research Institute for Oncology, Maastricht University Medical Centre+, Maastricht, the Netherlands., Essers M; Institute Verbeeten, Tilburg, the Netherlands., van Gestel CMJ; Zuidwest Radiotherapy Institute, Vlissingen, the Netherlands., Heemsbergen W; Dept. Radiotherapy, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, the Netherlands., Hoogeman M; Dept. Radiotherapy, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, the Netherlands; HollandPTC, Delft, the Netherlands., Immink M; Dept. Radiotherapy, Leiden University Medical Centre, the Netherlands., Klaver YLB; HollandPTC, Delft, the Netherlands; Dept. Radiotherapy, Leiden University Medical Centre, the Netherlands., Kroesen M; HollandPTC, Delft, the Netherlands., Langendijk JA; Dept. Radiation Oncology, University Medical Center Groningen, University of Groningen, the Netherlands., Maduro JH; Dept. Radiation Oncology, University Medical Center Groningen, University of Groningen, the Netherlands., Niezink AGH; Dept. Radiation Oncology, University Medical Center Groningen, University of Groningen, the Netherlands., Petoukhova AL; HollandPTC, Delft, the Netherlands; Dept. Medical Physics, Haaglanden Medical Centre, Den Haag, the Netherlands., Russell NS; Dept. Radiotherapy, the Netherlands Cancer Institute- Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Sattler MGA; Dept. Radiotherapy, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, the Netherlands; HollandPTC, Delft, the Netherlands., van der Schaaf A; Dept. Radiation Oncology, University Medical Center Groningen, University of Groningen, the Netherlands., Schuit E; Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands., Ta B; Dept. Radiation Oncology (Maastro), GROW Research Institute for Oncology, Maastricht University Medical Centre+, Maastricht, the Netherlands., Verhoeven K; Dept. Radiation Oncology (Maastro), GROW Research Institute for Oncology, Maastricht University Medical Centre+, Maastricht, the Netherlands., Hauptmann M; Dept. Epidemiology, the Netherlands Cancer Institute, Amsterdam, the Netherlands; Institute of Biostatistics and Registry Research, Brandenburg Medical School, Neuruppin, Germany., van Leeuwen F; Dept. Epidemiology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
Source: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2025 Sep; Vol. 210, pp. 110998. Date of Electronic Publication: 2025 Jul 05.
Publication Type: Journal Article; Review
Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0887 (Electronic) Linking ISSN: 01678140 NLM ISO Abbreviation: Radiother Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-0887
DOI:10.1016/j.radonc.2025.110998